Colloids (Blood Plasma) Industry Research Report 2024
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
According to APO Research, the global Colloids (Blood Plasma) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colloids (Blood Plasma), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloids (Blood Plasma).
The report will help the Colloids (Blood Plasma) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Colloids (Blood Plasma) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colloids (Blood Plasma) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Colloids (Blood Plasma) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Colloids (Blood Plasma) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
According to APO Research, the global Colloids (Blood Plasma) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colloids (Blood Plasma), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloids (Blood Plasma).
The report will help the Colloids (Blood Plasma) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Colloids (Blood Plasma) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colloids (Blood Plasma) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- CSL Behring
- Baxter
- Grifols
- Octapharma
- Kedrion
- Shanghai Raas
- CTBB
- Hualan Bio
- Rongsheng Pharmaceutical
- Boya Rongsheng
- B. Braun Medical
- Fresenius Kabi
- HOSPIRA
- Axa parenterals
- Fresenius Kabi (China)
- CR Double-Crane
- Kelun Group
- Shandong Qidu Pharmaceutical
- Shandong Hualu Pharmaceutical
- Minsheng Pharma
- Kanglepharm
- Natural Type Colloids (Blood Plasma)
- Synthetic Type Colloids (Blood Plasma)
- Extensive Burns
- Massive Blood or Plasma Loss
- Hypovolemic Shock
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Colloids (Blood Plasma) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Colloids (Blood Plasma) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Colloids (Blood Plasma) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Colloids (Blood Plasma) Sales (2019-2030)
2.2.3 Global Colloids (Blood Plasma) Market Average Price (2019-2030)
2.3 Colloids (Blood Plasma) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Natural Type Colloids (Blood Plasma)
2.3.3 Synthetic Type Colloids (Blood Plasma)
2.4 Colloids (Blood Plasma) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Extensive Burns
2.4.3 Massive Blood or Plasma Loss
2.4.4 Hypovolemic Shock
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Colloids (Blood Plasma) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Colloids (Blood Plasma) Sales (MT) of Manufacturers (2019-2024)
3.3 Global Colloids (Blood Plasma) Revenue of Manufacturers (2019-2024)
3.4 Global Colloids (Blood Plasma) Average Price by Manufacturers (2019-2024)
3.5 Global Colloids (Blood Plasma) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Colloids (Blood Plasma), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Colloids (Blood Plasma), Product Type & Application
3.8 Global Manufacturers of Colloids (Blood Plasma), Date of Enter into This Industry
3.9 Global Colloids (Blood Plasma) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 CSL Behring
4.1.1 CSL Behring Company Information
4.1.2 CSL Behring Business Overview
4.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
4.1.5 CSL Behring Recent Developments
4.2 Baxter
4.2.1 Baxter Company Information
4.2.2 Baxter Business Overview
4.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
4.2.5 Baxter Recent Developments
4.3 Grifols
4.3.1 Grifols Company Information
4.3.2 Grifols Business Overview
4.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
4.3.5 Grifols Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
4.4.5 Octapharma Recent Developments
4.5 Kedrion
4.5.1 Kedrion Company Information
4.5.2 Kedrion Business Overview
4.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
4.5.5 Kedrion Recent Developments
4.6 Shanghai Raas
4.6.1 Shanghai Raas Company Information
4.6.2 Shanghai Raas Business Overview
4.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
4.6.5 Shanghai Raas Recent Developments
4.7 CTBB
4.7.1 CTBB Company Information
4.7.2 CTBB Business Overview
4.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
4.7.5 CTBB Recent Developments
4.8 Hualan Bio
4.8.1 Hualan Bio Company Information
4.8.2 Hualan Bio Business Overview
4.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
4.8.5 Hualan Bio Recent Developments
4.9 Rongsheng Pharmaceutical
4.9.1 Rongsheng Pharmaceutical Company Information
4.9.2 Rongsheng Pharmaceutical Business Overview
4.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.9.5 Rongsheng Pharmaceutical Recent Developments
4.10 Boya Rongsheng
4.10.1 Boya Rongsheng Company Information
4.10.2 Boya Rongsheng Business Overview
4.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
4.10.5 Boya Rongsheng Recent Developments
4.11 B. Braun Medical
4.11.1 B. Braun Medical Company Information
4.11.2 B. Braun Medical Business Overview
4.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
4.11.5 B. Braun Medical Recent Developments
4.12 Fresenius Kabi
4.12.1 Fresenius Kabi Company Information
4.12.2 Fresenius Kabi Business Overview
4.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
4.12.5 Fresenius Kabi Recent Developments
4.13 HOSPIRA
4.13.1 HOSPIRA Company Information
4.13.2 HOSPIRA Business Overview
4.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
4.13.5 HOSPIRA Recent Developments
4.14 Axa parenterals
4.14.1 Axa parenterals Company Information
4.14.2 Axa parenterals Business Overview
4.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
4.14.5 Axa parenterals Recent Developments
4.15 Fresenius Kabi (China)
4.15.1 Fresenius Kabi (China) Company Information
4.15.2 Fresenius Kabi (China) Business Overview
4.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
4.15.5 Fresenius Kabi (China) Recent Developments
4.16 CR Double-Crane
4.16.1 CR Double-Crane Company Information
4.16.2 CR Double-Crane Business Overview
4.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
4.16.5 CR Double-Crane Recent Developments
4.17 Kelun Group
4.17.1 Kelun Group Company Information
4.17.2 Kelun Group Business Overview
4.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
4.17.5 Kelun Group Recent Developments
4.18 Shandong Qidu Pharmaceutical
4.18.1 Shandong Qidu Pharmaceutical Company Information
4.18.2 Shandong Qidu Pharmaceutical Business Overview
4.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.18.5 Shandong Qidu Pharmaceutical Recent Developments
4.19 Shandong Hualu Pharmaceutical
4.19.1 Shandong Hualu Pharmaceutical Company Information
4.19.2 Shandong Hualu Pharmaceutical Business Overview
4.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.19.5 Shandong Hualu Pharmaceutical Recent Developments
4.20 Minsheng Pharma
4.20.1 Minsheng Pharma Company Information
4.20.2 Minsheng Pharma Business Overview
4.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
4.20.5 Minsheng Pharma Recent Developments
4.21 Kanglepharm
4.21.1 Kanglepharm Company Information
4.21.2 Kanglepharm Business Overview
4.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
4.21.5 Kanglepharm Recent Developments
5 GLOBAL COLLOIDS (BLOOD PLASMA) MARKET SCENARIO BY REGION
5.1 Global Colloids (Blood Plasma) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Colloids (Blood Plasma) Sales by Region: 2019-2030
5.2.1 Global Colloids (Blood Plasma) Sales by Region: 2019-2024
5.2.2 Global Colloids (Blood Plasma) Sales by Region: 2025-2030
5.3 Global Colloids (Blood Plasma) Revenue by Region: 2019-2030
5.3.1 Global Colloids (Blood Plasma) Revenue by Region: 2019-2024
5.3.2 Global Colloids (Blood Plasma) Revenue by Region: 2025-2030
5.4 North America Colloids (Blood Plasma) Market Facts & Figures by Country
5.4.1 North America Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Colloids (Blood Plasma) Sales by Country (2019-2030)
5.4.3 North America Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Colloids (Blood Plasma) Market Facts & Figures by Country
5.5.1 Europe Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Colloids (Blood Plasma) Sales by Country (2019-2030)
5.5.3 Europe Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Colloids (Blood Plasma) Market Facts & Figures by Country
5.6.1 Asia Pacific Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Colloids (Blood Plasma) Sales by Country (2019-2030)
5.6.3 Asia Pacific Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Colloids (Blood Plasma) Market Facts & Figures by Country
5.7.1 Latin America Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Colloids (Blood Plasma) Sales by Country (2019-2030)
5.7.3 Latin America Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country
5.8.1 Middle East and Africa Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Colloids (Blood Plasma) Sales by Type (2019-2030)
6.1.1 Global Colloids (Blood Plasma) Sales by Type (2019-2030) & (MT)
6.1.2 Global Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
6.2 Global Colloids (Blood Plasma) Revenue by Type (2019-2030)
6.2.1 Global Colloids (Blood Plasma) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
6.3 Global Colloids (Blood Plasma) Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Colloids (Blood Plasma) Sales by Application (2019-2030)
7.1.1 Global Colloids (Blood Plasma) Sales by Application (2019-2030) & (MT)
7.1.2 Global Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
7.2 Global Colloids (Blood Plasma) Revenue by Application (2019-2030)
7.2.1 Global Colloids (Blood Plasma) Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
7.3 Global Colloids (Blood Plasma) Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Colloids (Blood Plasma) Value Chain Analysis
8.1.1 Colloids (Blood Plasma) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Colloids (Blood Plasma) Production Mode & Process
8.2 Colloids (Blood Plasma) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Colloids (Blood Plasma) Distributors
8.2.3 Colloids (Blood Plasma) Customers
9 GLOBAL COLLOIDS (BLOOD PLASMA) ANALYZING MARKET DYNAMICS
9.1 Colloids (Blood Plasma) Industry Trends
9.2 Colloids (Blood Plasma) Industry Drivers
9.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
9.4 Colloids (Blood Plasma) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Colloids (Blood Plasma) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Colloids (Blood Plasma) Sales (2019-2030)
2.2.3 Global Colloids (Blood Plasma) Market Average Price (2019-2030)
2.3 Colloids (Blood Plasma) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Natural Type Colloids (Blood Plasma)
2.3.3 Synthetic Type Colloids (Blood Plasma)
2.4 Colloids (Blood Plasma) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Extensive Burns
2.4.3 Massive Blood or Plasma Loss
2.4.4 Hypovolemic Shock
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Colloids (Blood Plasma) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Colloids (Blood Plasma) Sales (MT) of Manufacturers (2019-2024)
3.3 Global Colloids (Blood Plasma) Revenue of Manufacturers (2019-2024)
3.4 Global Colloids (Blood Plasma) Average Price by Manufacturers (2019-2024)
3.5 Global Colloids (Blood Plasma) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Colloids (Blood Plasma), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Colloids (Blood Plasma), Product Type & Application
3.8 Global Manufacturers of Colloids (Blood Plasma), Date of Enter into This Industry
3.9 Global Colloids (Blood Plasma) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 CSL Behring
4.1.1 CSL Behring Company Information
4.1.2 CSL Behring Business Overview
4.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
4.1.5 CSL Behring Recent Developments
4.2 Baxter
4.2.1 Baxter Company Information
4.2.2 Baxter Business Overview
4.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
4.2.5 Baxter Recent Developments
4.3 Grifols
4.3.1 Grifols Company Information
4.3.2 Grifols Business Overview
4.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
4.3.5 Grifols Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
4.4.5 Octapharma Recent Developments
4.5 Kedrion
4.5.1 Kedrion Company Information
4.5.2 Kedrion Business Overview
4.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
4.5.5 Kedrion Recent Developments
4.6 Shanghai Raas
4.6.1 Shanghai Raas Company Information
4.6.2 Shanghai Raas Business Overview
4.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
4.6.5 Shanghai Raas Recent Developments
4.7 CTBB
4.7.1 CTBB Company Information
4.7.2 CTBB Business Overview
4.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
4.7.5 CTBB Recent Developments
4.8 Hualan Bio
4.8.1 Hualan Bio Company Information
4.8.2 Hualan Bio Business Overview
4.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
4.8.5 Hualan Bio Recent Developments
4.9 Rongsheng Pharmaceutical
4.9.1 Rongsheng Pharmaceutical Company Information
4.9.2 Rongsheng Pharmaceutical Business Overview
4.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.9.5 Rongsheng Pharmaceutical Recent Developments
4.10 Boya Rongsheng
4.10.1 Boya Rongsheng Company Information
4.10.2 Boya Rongsheng Business Overview
4.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
4.10.5 Boya Rongsheng Recent Developments
4.11 B. Braun Medical
4.11.1 B. Braun Medical Company Information
4.11.2 B. Braun Medical Business Overview
4.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
4.11.5 B. Braun Medical Recent Developments
4.12 Fresenius Kabi
4.12.1 Fresenius Kabi Company Information
4.12.2 Fresenius Kabi Business Overview
4.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
4.12.5 Fresenius Kabi Recent Developments
4.13 HOSPIRA
4.13.1 HOSPIRA Company Information
4.13.2 HOSPIRA Business Overview
4.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
4.13.5 HOSPIRA Recent Developments
4.14 Axa parenterals
4.14.1 Axa parenterals Company Information
4.14.2 Axa parenterals Business Overview
4.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
4.14.5 Axa parenterals Recent Developments
4.15 Fresenius Kabi (China)
4.15.1 Fresenius Kabi (China) Company Information
4.15.2 Fresenius Kabi (China) Business Overview
4.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
4.15.5 Fresenius Kabi (China) Recent Developments
4.16 CR Double-Crane
4.16.1 CR Double-Crane Company Information
4.16.2 CR Double-Crane Business Overview
4.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
4.16.5 CR Double-Crane Recent Developments
4.17 Kelun Group
4.17.1 Kelun Group Company Information
4.17.2 Kelun Group Business Overview
4.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
4.17.5 Kelun Group Recent Developments
4.18 Shandong Qidu Pharmaceutical
4.18.1 Shandong Qidu Pharmaceutical Company Information
4.18.2 Shandong Qidu Pharmaceutical Business Overview
4.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.18.5 Shandong Qidu Pharmaceutical Recent Developments
4.19 Shandong Hualu Pharmaceutical
4.19.1 Shandong Hualu Pharmaceutical Company Information
4.19.2 Shandong Hualu Pharmaceutical Business Overview
4.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.19.5 Shandong Hualu Pharmaceutical Recent Developments
4.20 Minsheng Pharma
4.20.1 Minsheng Pharma Company Information
4.20.2 Minsheng Pharma Business Overview
4.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
4.20.5 Minsheng Pharma Recent Developments
4.21 Kanglepharm
4.21.1 Kanglepharm Company Information
4.21.2 Kanglepharm Business Overview
4.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
4.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
4.21.5 Kanglepharm Recent Developments
5 GLOBAL COLLOIDS (BLOOD PLASMA) MARKET SCENARIO BY REGION
5.1 Global Colloids (Blood Plasma) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Colloids (Blood Plasma) Sales by Region: 2019-2030
5.2.1 Global Colloids (Blood Plasma) Sales by Region: 2019-2024
5.2.2 Global Colloids (Blood Plasma) Sales by Region: 2025-2030
5.3 Global Colloids (Blood Plasma) Revenue by Region: 2019-2030
5.3.1 Global Colloids (Blood Plasma) Revenue by Region: 2019-2024
5.3.2 Global Colloids (Blood Plasma) Revenue by Region: 2025-2030
5.4 North America Colloids (Blood Plasma) Market Facts & Figures by Country
5.4.1 North America Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Colloids (Blood Plasma) Sales by Country (2019-2030)
5.4.3 North America Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Colloids (Blood Plasma) Market Facts & Figures by Country
5.5.1 Europe Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Colloids (Blood Plasma) Sales by Country (2019-2030)
5.5.3 Europe Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Colloids (Blood Plasma) Market Facts & Figures by Country
5.6.1 Asia Pacific Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Colloids (Blood Plasma) Sales by Country (2019-2030)
5.6.3 Asia Pacific Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Colloids (Blood Plasma) Market Facts & Figures by Country
5.7.1 Latin America Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Colloids (Blood Plasma) Sales by Country (2019-2030)
5.7.3 Latin America Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country
5.8.1 Middle East and Africa Colloids (Blood Plasma) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Colloids (Blood Plasma) Sales by Type (2019-2030)
6.1.1 Global Colloids (Blood Plasma) Sales by Type (2019-2030) & (MT)
6.1.2 Global Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
6.2 Global Colloids (Blood Plasma) Revenue by Type (2019-2030)
6.2.1 Global Colloids (Blood Plasma) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
6.3 Global Colloids (Blood Plasma) Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Colloids (Blood Plasma) Sales by Application (2019-2030)
7.1.1 Global Colloids (Blood Plasma) Sales by Application (2019-2030) & (MT)
7.1.2 Global Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
7.2 Global Colloids (Blood Plasma) Revenue by Application (2019-2030)
7.2.1 Global Colloids (Blood Plasma) Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
7.3 Global Colloids (Blood Plasma) Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Colloids (Blood Plasma) Value Chain Analysis
8.1.1 Colloids (Blood Plasma) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Colloids (Blood Plasma) Production Mode & Process
8.2 Colloids (Blood Plasma) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Colloids (Blood Plasma) Distributors
8.2.3 Colloids (Blood Plasma) Customers
9 GLOBAL COLLOIDS (BLOOD PLASMA) ANALYZING MARKET DYNAMICS
9.1 Colloids (Blood Plasma) Industry Trends
9.2 Colloids (Blood Plasma) Industry Drivers
9.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
9.4 Colloids (Blood Plasma) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
